These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37668357)

  • 1. Perceptions of Controversies and Unresolved Issues in the 2014 FIGO Staging System for Endometrial Cancer: Survey Results From Members of the International Society of Gynecological Pathologists and International Gynecologic Cancer Society.
    Kayraklioglu N; Katsakhyan L; Cohen PA; Singh N; Rabban JT; Matias-Guiu X
    Int J Gynecol Pathol; 2024 May; 43(3):242-252. PubMed ID: 37668357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
    Soslow RA; Tornos C; Park KJ; Malpica A; Matias-Guiu X; Oliva E; Parkash V; Carlson J; McCluggage WG; Gilks CB
    Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S64-S74. PubMed ID: 30550484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists.
    Malpica A; Euscher ED; Hecht JL; Ali-Fehmi R; Quick CM; Singh N; Horn LC; Alvarado-Cabrero I; Matias-Guiu X; Hirschowitz L; Duggan M; Ordi J; Parkash V; Mikami Y; Ruhul Quddus M; Zaino R; Staebler A; Zaloudek C; McCluggage WG; Oliva E
    Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S9-S24. PubMed ID: 30550481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists.
    Park KJ; Roma A; Singh N; Gilks CB; Oliva E; Abu-Rustum N; Ramirez PT; McCluggage WG
    Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S92-S101. PubMed ID: 33570866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer.
    Gravbrot N; Weil CR; DeCesaris CM; Gaffney DK; Suneja G; Burt LM
    Eur J Cancer; 2024 Apr; 201():113913. PubMed ID: 38377777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphovascular Space Invasion for Endometrial Cancer: Undertreatment and Overtreatment Risks: A Survey of the Spanish Gynecologic Oncology Group.
    Gorostidi Pulgar M; Diaz de la Noval B; Gil-Ibañez B; Lago Leal V; Jaunarena Marin I; Padilla Iserte P
    Int J Gynecol Cancer; 2017 Jul; 27(6):1191-1199. PubMed ID: 28557833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIGO 2023 endometrial cancer staging: too much, too soon?
    McCluggage WG; Bosse T; Gilks CB; Howitt BE; McAlpine JN; Nucci MR; Rabban JT; Singh N; Talia KL; Parra-Herran C
    Int J Gynecol Cancer; 2023 Nov; ():. PubMed ID: 37935523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues and inconsistencies in the revised gynecologic staging systems.
    Cole L; Stoler MH
    Semin Diagn Pathol; 2012 Aug; 29(3):167-73. PubMed ID: 23062423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FIGO staging of endometrial cancer: 2023.
    Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
    Int J Gynaecol Obstet; 2023 Aug; 162(2):383-394. PubMed ID: 37337978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.
    Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Peregrin I; Mendizabal E; Ortiz-Quintana L
    Int J Gynecol Cancer; 2015 Jan; 25(1):49-54. PubMed ID: 25405578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node mapping in endometrial and cervical cancer: a survey of practices and attitudes in gynecologic oncologists.
    Chambers LM; Vargas R; Michener CM
    J Gynecol Oncol; 2019 May; 30(3):e35. PubMed ID: 30887757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microcystic, elongated, and fragmented pattern invasion is mainly associated with isolated tumor cell pattern metastases in International Federation of Gynecology and Obstetrics grade I endometrioid endometrial cancer.
    Pelletier MP; Trinh VQ; Stephenson P; Mes-Masson AM; Samouelian V; Provencher DM; Rahimi K
    Hum Pathol; 2017 Apr; 62():33-39. PubMed ID: 27864117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial cancer risk factors, treatment, and survival outcomes as per the European Society for Medical Oncology (ESMO) - European Society of Gynaecological Oncology (ESGO) - European Society for Radiotherapy and Oncology (ESTRO) risk groups and International Federation of Gynecology and Obstetrics (FIGO) staging: An experience from developing world.
    Gupta N; Pandey A; Dimri K; Sehgal A; Bhagat R; Suraj ; Gill G
    J Cancer Res Ther; 2023; 19(3):701-707. PubMed ID: 37470597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
    Kosary CL
    Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Extraordinary Location of Sentinel Lymph Nodes in a Patient with Endometrial Cancer.
    Comba C; Aslan E; Vatankulu B; Tatar Z; Demir AA; Demir O
    J Minim Invasive Gynecol; 2023 Aug; 30(8):613-614. PubMed ID: 37137423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
    Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
    Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel Lymph Node Biopsies in Endometrial Cancer: Practice Patterns among Gynecologic Oncologists in the United States.
    Renz M; Diver E; English D; Kidd E; Dorigo O; Karam A
    J Minim Invasive Gynecol; 2020 Feb; 27(2):482-488. PubMed ID: 30980995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.
    Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V
    Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.